Central proliferation and neurogenesis is impaired in type 2 diabetes and prediabetes animal models.
Type 2 diabetes (T2D) is an important risk factor to suffer dementia, including Alzheimer's disease (AD), and some neuropathological features observed in dementia could be mediated by T2D metabolic alterations. Since brain atrophy and impaired neurogenesis have been observed both T2D and AD we...
| 出版年: | PLoS ONE |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | 論文 |
| 言語: | 英語 |
| 出版事項: |
Public Library of Science (PLoS)
2014-01-01
|
| オンライン・アクセス: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0089229&type=printable |
